Feed SXTP
SX

60 Degrees Pharmaceuticals, Inc. SXTP · NASDAQ

$0.86 -4.84% (-$0.04)

Summary

44 / 100 · Bulios Score

What speaks for it

  • Revenue grew by 65% a year over the last 3 years.
  • It has no debt and holds $1.02M in cash.
  • The share price is below the Bulios Fair Price.

What to watch

  • The company made a loss over the last 12 months.
  • It missed profit estimates 7 times in the last 8 quarters.
  • It passes only 2 of the 9 points of the Piotroski financial health test.

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Score in detail

Price

Is it expensive?

Looks cheap
Bulios Fair Price
Current price $0.86

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

The company made a loss over the last 12 months, so there is no profit to set the price against.

Valuation in detail

Is it growing?

Yes, fast

Revenue (USD)

Diluted EPS (USD)

  • Analyst estimate

Revenue fell by 14% a year over 5 years. Over the last 3 years it grew by 65% a year.

Growth in detail

Does it make money?

Poorly

Over the last 12 months it made a loss of $8.11M.

Profitability in detail

Is it financially healthy?

Yes

It has no debt.

Financial health in detail

Does it pay a dividend?

No

It pays no dividend.

Dividends in detail

What do analysts expect?

Mildly positive

No analyst has published a price target.

50% of the analysts recommend buying.

Analysts in detail

What does it earn on?

By product

The company reports no revenue by product.

By region

The company reports no revenue by region.

Segments in detail

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.